Diagnosis: Porphyria cutanea tarda
A 45-year-old female presents with tense vesicles and milia on her dorsal hands following sun exposure over the past few months. The lesions are accompanied by a burning sensation and have progressively worsened. Key laboratory findings reveal elevated levels of uroporphyrins, leading to a diagnosis of porphyria cutanea tarda.
A 45-year-old female presents with a 3-month history of tense vesicular lesions and milia on her dorsal hands, which developed after increased sun exposure. The lesions are pruritic and painful, and the patient reports difficulty with daily activities due to skin fragility. Examination reveals multiple tense vesicles, crusted erosions, and milia on the dorsal surfaces of both hands.Tense vesicles: Notable on the dorsal hands, indicating fragility.Milia: Present in areas of prior vesicular eruptions.Crusting: Observed on some lesions, suggesting secondary infection.Skin fragility: Increased susceptibility to trauma noted during examination.Hyperpigmentation: Areas of post-inflammatory hyperpigmentation surrounding the lesions.
The patient reports that her skin lesions began approximately three months ago after a vacation in a sunny location. She has a history of intermittent alcohol use and is otherwise healthy with no prior skin conditions. Family history is significant for liver disease, but there are no known cases of porphyria. She has not received any dermatologic treatments prior to this presentation.Onset: Lesions began after increased sun exposure.Triggers: Recent vacation and alcohol consumption.Prior treatments: No previous dermatologic interventions.Relevant history: No significant past medical history, no known liver disease.Family history: Positive for liver disease.
Acute / First-Line ManagementSun protection: Advise strict photoprotection with broad-spectrum sunscreen (SPF 30 or higher) and protective clothing.Phlebotomy: Considered for patients with elevated iron levels; typically performed every 1-2 weeks until ferritin levels normalize.Hydroxychloroquine: 200-400 mg daily may be used in cases resistant to phlebotomy.Workup and Diagnostic ConfirmationUrinary porphyrin levels: Elevated uroporphyrins in a 24-hour urine collection.Serum porphyrin levels: Increased total porphyrins may assist in diagnosis.Liver function tests: Assess for liver involvement and rule out other liver disease.Long-Term ManagementAlcohol cessation: Strongly recommended to prevent exacerbation of symptoms.Regular follow-up: Monitor for skin lesions and liver function.Education: Patients should be educated about avoiding sun exposure and potential triggers.
Dermatitis herpetiformis: Characterized by pruritic vesicles and associated with gluten sensitivity; usually presents bilaterally on extensor surfaces.Bullous pemphigoid: Typically occurs in older adults, presents with tense blisters; positive direct immunofluorescence helps confirm diagnosis.Chronic actinic dermatitis: Erythematous, scaly patches on sun-exposed areas, often with a history of photosensitivity.Acne vulgaris: Can present with cysts and scarring; however, lesions are typically on the face and upper body.Steatocystoma multiplex: Multiple sebaceous cysts, often familial; does not typically show vesicular lesions.Porphyria cutanea tarda: Characterized by photosensitivity and skin fragility, confirmed by elevated porphyrin levels.
High-Yield PearlsPhotosensitivity: Key feature in porphyria cutanea tarda; lesions often occur on sun-exposed areas.Uroporphyrin levels: Elevated in urine confirm diagnosis; important to differentiate from other skin conditions.Alcohol impact: Alcohol is a significant exacerbating factor; cessation is crucial for management.Dermatologic management: Focus on sun protection and potential pharmacotherapy such as hydroxychloroquine.Family history: Important to assess, as genetic predisposition may be a factor.Porphyria cutanea tarda is a condition where sun exposure and alcohol consumption can lead to significant skin changes, necessitating a multidisciplinary approach for management.
Tags: PCT, porphyria, uroporphyrinogen decarboxylase